Abstract
Acylcarnitines are important diagnostic markers for inborn errors of fatty acid oxidation, but their analysis in body fluids may not always be reliable. Recently, disease-specific acylcarnitine profiles generated by cultured skin fibroblasts were reported to facilitate the diagnosis by localizing a specific enzymatic defect in the mitochondrial β-oxidation pathway. Using a novel methodologic approach, fibroblasts from 16 patients with inborn errors of fatty acid oxidation and 13 control subjects were preincubated with L-[3H]carnitine to label the intracellular carnitine pool. Cells were subsequently incubated with unlabeled palmitic acid and, after methanol extraction of cells and media, labeled free carnitine and acylcarnitines were analyzed by radio-HPLC. Quantitation was based on the integrated radioactivity of individual peaks relative to the total radioactivity recovered. In control cell lines, all saturated acylcarnitines were detected, and reference values were established. With the exception of one cell line deficient in electron transfer flavoprotein, all mutant cell lines showed abnormal and disease-specific relative concentrations of acylcarnitines. Advantages of the method include use of a small number of cells, no need for trypsinization and permeabilization of cells before incubation, simple extraction without purification of the specimen before HPLC, and relatively inexpensive equipment. The method allows a focused approach to the subsequent, more laborious confirmation of a particular disease by direct enzymatic and/or molecular analysis. It remains to be established whether the method can replace widely used global measurements of fatty acid oxidation rates in vitro that do not provide specific information about the enzyme deficiency involved.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
Abbreviations
- AC:
-
acylcarnitine(s)
- CPT:
-
carnitine palmitoyltransferase
- VLCAD:
-
very long chain acyl-CoA dehydrogenase
- TFE:
-
trifunctional enzyme
- LCHAD:
-
long chain 3-hydroxy acyl-CoA dehydrogenase
- MCAD:
-
medium chain acyl-CoA dehydrogenase
- SCAD:
-
short chain acyl-CoA dehydrogenase
- ETF-α:
-
electron transfer flavoprotein α-subunit
- DH:
-
dehydrogenase
References
Roe CR, Coates PM 1995 Mitochondrial fatty acid oxidation disorders. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The Metabolic and Molecular Bases of Inherited Disease. McGraw-Hill, New York, pp 1501–1533
Vockley J 1994 The changing face of disorders of fatty acid oxidation. Mayo Clin Proc 69: 249–257
Schmidt-Sommerfeld E, Penn D, Kerner J, Bieber LL, Rossi TM, Lebenthal E 1989 Quantitation of urinary carnitine esters in a patient with medium chain acyl-coenzyme A dehydrogenase deficiency: effect of metabolic state and L-carnitine therapy. J Pediatr 115: 577–582
Pourfarzam M, Schaefer J, Turnbull DM, Bartlett K 1994 Analysis of fatty acid oxidation intermediates in cultured fibroblasts to detect mitochondrial oxidation disorders. Clin Chem 12: 2267–2275
Nada MA, Rhead WJ, Sprecher H, Schulz H, Roe CR 1995 Evidence for intermediate channeling in mitochondrial β-oxidation. J Biol Chem 270: 530–535
Schaefer J, Pourfarzam M, Bartlett K, Jackson S, Turnbull DM 1995 Fatty acid oxidation in peripheral blood cells: characterization and use for the diagnosis of defects of fatty acid oxidation. Pediatr Res 37: 354–360
Nada MA, Chace DH, Sprecher H, Roe CR 1995 Investigation of β-oxidation intermediates in normal and MCAD-deficient human fibroblasts using tandem mass spectrometry. Biochem Mol Med 54: 59–66
Naito E, Indo Y, Tanaka K 1990 Identification of two variant short chain acylcoenzyme A dehydrogenase alleles, each containing a different point mutation in a patient with short chain acyl-coenzyme A dehydrogenase deficiency. J Clin Invest 85: 1575–1582
Schmidt-Sommerfeld E, Zhang L, Bobrowski PJ, Penn D 1995 Quantitation of short-and medium-chain acylcarnitines in plasma by radioisotopic exchange/high-performance liquid chromatography. Anal Biochem 231: 27–33
Bohmer T, Bremer J 1986 Propionylcarnitine, physiological variations in vivo. Biochim Biophys Acta 152: 559–567
Burlina AB, Dioniso-Vici C, Bennett MJ, Gibson KM, Servideo S, Bertini E, Hale DE, Schmidt-Sommerfeld E, Sabetta G, Facchello F, Rinaldo P 1994 A new syndrome with ethylmalonic aciduria and normal fatty acid oxidation in fibroblasts. J Pediatr 124: 79–86
Bhala A, Willi SM, Rinaldo P, Bennett MJ, Schmidt-Sommerfeld E, Hale DE 1995 Clinical and biochemical characterization of short-chain acyl-CoA dehydrogenase deficiency. J Pediatr 126: 910–915
Bieber LL, Kerner J 1986 Short-chain acyl carnitines: identification and quantitation. Methods Enzymol 123: 264–276
Loehr JP, Goodman SI, Frerman FE 1990 Glutaric acidemia type II: heterogeneity of clinical and biochemical phenotypes. Pediatr Res 27: 311–315
Saudubray JM, Coude FX, Demaugre F, Johnson C, Gibson KM, Nyhan WL 1982 Oxidation of fatty acids in cultured fibroblasts: a model system for the detection and study of defects in oxidation. Pediatr Res 16: 877–881
Rhead WJ 1990 Screening for inborn errors of fatty acid oxidation in cultured fibroblasts: an overview. In: Tanaka K, Coates PM(eds) Fatty Acid Oxidation: Clinical, Biochemical and Molecular Aspects. Alan R Liss, New York, pp 365–382
Acknowledgements
The authors thank Lodewijk IJlst for synthesizing the long chain acyl-CoA esters and Pat Davillier for expert assistance in preparing this manuscript.
Author information
Authors and Affiliations
Additional information
Supported, in part, by U.S. Public Health Service Grant HD29273 and by a grant from the American Heart Association-LA Affiliate, Inc.
Rights and permissions
About this article
Cite this article
Schmidt-Sommerfeld, E., Bobrowski, P., Penn, D. et al. Analysis of Carnitine Esters by Radio-High Performance Liquid Chromatography in Cultured Skin Fibroblasts from Patients with Mitochondrial Fatty Acid Oxidation Disorders. Pediatr Res 44, 210–214 (1998). https://doi.org/10.1203/00006450-199808000-00012
Received:
Accepted:
Issue date:
DOI: https://doi.org/10.1203/00006450-199808000-00012
This article is cited by
-
Novel ETF dehydrogenase mutations in a patient with mild glutaric aciduria type II and complex II‐III deficiency in liver and muscle
Journal of Inherited Metabolic Disease (2010)
-
Analysis of plasma free fatty acid cyanomethyl derivatives by GC-NPD for the diagnosis of mitochondrial fatty acid oxidation disorders
Chromatographia (2000)
